Abstract
Infectious agents such as human immune deficiency virus-1 (HIV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) use host proteins to infect, replicate, and induce inflammation within the host. A critical component of these diseases is the axis between pannexin-1 channels, extracellular ATP, and purinergic receptors. Here, we describe the potential therapeutic role of Pannexin-1/purinergic approaches to prevent or reduce the devastating consequences of these pathogens.
Original language | English (US) |
---|---|
Article number | 102404 |
Journal | Current Opinion in Pharmacology |
Volume | 73 |
DOIs | |
State | Published - Dec 2023 |
Keywords
- ATP
- COVID-19
- Connexin
- Gap junctions
- Hemichannels
- NeuroHIV
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery